Cite
APA Citation
Lampert, E. J., Cimino-Mathews, A., Lee, J. S., Nair, J., Lee, M., Yuno, A., An, D., Trepel, J. B., Ruppin, E., & Lee, J. (2020). clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Journal for immunotherapy of cancer, 8(2), . http://access.bl.uk/ark:/81055/vdc_100127560009.0x000024